Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02221960
Title A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site New Haven Connecticut 06520 United States Details
Research Site Washington District of Columbia 20007 United States Details
Research Site Chicago Illinois 60611 United States Details
Research Site New York New York 10065 United States Details
Research Site Portland Oregon 97213 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Parkville 3052 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field